These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16891068)

  • 21. Furan-functionalized co-polymers for targeted drug delivery: characterization, self-assembly and drug encapsulation.
    Shi M; Shoichet MS
    J Biomater Sci Polym Ed; 2008; 19(9):1143-57. PubMed ID: 18727857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sustained release of bee venom peptide from biodegradable thermosensitive PLGA-PEG-PLGA triblock copolymer-based hydrogels in vitro.
    Qiao M; Chen D; Ma X; Hu H
    Pharmazie; 2006 Mar; 61(3):199-202. PubMed ID: 16599259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation and characterization novel polymer-coated magnetic nanoparticles as carriers for doxorubicin.
    Li F; Sun J; Zhu H; Wen X; Lin C; Shi D
    Colloids Surf B Biointerfaces; 2011 Nov; 88(1):58-62. PubMed ID: 21764271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral nuclear factor-κB decoy oligonucleotides delivery system with chitosan modified poly(D,L-lactide-co-glycolide) nanospheres for inflammatory bowel disease.
    Tahara K; Samura S; Tsuji K; Yamamoto H; Tsukada Y; Bando Y; Tsujimoto H; Morishita R; Kawashima Y
    Biomaterials; 2011 Jan; 32(3):870-8. PubMed ID: 20934748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Poly[lactic-co-(glycolic acid)]-grafted hyaluronic acid copolymer micelle nanoparticles for target-specific delivery of doxorubicin.
    Lee H; Ahn CH; Park TG
    Macromol Biosci; 2009 Apr; 9(4):336-42. PubMed ID: 19006195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An innovative, quick and convenient labeling method for the investigation of pharmacological behavior and the metabolism of poly(DL-lactide-co-glycolide) nanospheres.
    Stevanović M; Maksin T; Petković J; Filipic M; Uskoković D
    Nanotechnology; 2009 Aug; 20(33):335102. PubMed ID: 19636100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content.
    Budhian A; Siegel SJ; Winey KI
    Int J Pharm; 2007 May; 336(2):367-75. PubMed ID: 17207944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polyelectrolyte complex of chondroitin sulfate and peptide with lower pI value in poly(lactide-co-glycolide) microsphere for stability and controlled release.
    Park W; Na K
    Colloids Surf B Biointerfaces; 2009 Sep; 72(2):193-200. PubMed ID: 19414243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Poly(D,L-lactide-co-glycolide)/hydroxyapatite core-shell nanospheres. Part 3: properties of hydroxyapatite nano-rods and investigation of a distribution of the drug within the composite.
    Vukomanović M; Zavašnik-Bergant T; Bračko I; Skapin SD; Ignjatović N; Radmilović V; Uskoković D
    Colloids Surf B Biointerfaces; 2011 Oct; 87(2):226-35. PubMed ID: 21723099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation and characterization of cationic PLGA nanospheres as DNA carriers.
    Ravi Kumar MN; Bakowsky U; Lehr CM
    Biomaterials; 2004 May; 25(10):1771-7. PubMed ID: 14738840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of bee venom peptide-copolymer interactions on thermosensitive hydrogel delivery systems.
    Qiao M; Chen D; Hao T; Zhao X; Hu H; Ma X
    Int J Pharm; 2007 Dec; 345(1-2):116-24. PubMed ID: 17629639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of lung surfactants on rifampicin release rate from monodisperse rifampicin-loaded PLGA microspheres.
    Tomoda K; Makino K
    Colloids Surf B Biointerfaces; 2007 Mar; 55(1):115-24. PubMed ID: 17197161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ciprofloxacin-encapsulated poly(DL-lactide-co-glycolide) nanoparticles and its antibacterial activity.
    Jeong YI; Na HS; Seo DH; Kim DG; Lee HC; Jang MK; Na SK; Roh SH; Kim SI; Nah JW
    Int J Pharm; 2008 Mar; 352(1-2):317-23. PubMed ID: 18160236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and characterization of highly-magnetic biodegradable poly(d,l-lactide-co-glycolide) nanospheres.
    Liu X; Kaminski MD; Chen H; Torno M; Taylor L; Rosengart AJ
    J Control Release; 2007 May; 119(1):52-8. PubMed ID: 17350131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and characterization of PLGA nanospheres and nanocapsules containing xanthone and 3-methoxyxanthone.
    Teixeira M; Alonso MJ; Pinto MM; Barbosa CM
    Eur J Pharm Biopharm; 2005 Apr; 59(3):491-500. PubMed ID: 15760730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced surface attachment of protein-type targeting ligands to poly(lactide-co-glycolide) nanoparticles using variable expression of polymeric acid functionality.
    McCarron PA; Marouf WM; Donnelly RF; Scott C
    J Biomed Mater Res A; 2008 Dec; 87(4):873-84. PubMed ID: 18228271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Composites of poly(lactide-co-glycolide) and the surface modified carbonated hydroxyapatite nanoparticles.
    Hong Z; Zhang P; Liu A; Chen L; Chen X; Jing X
    J Biomed Mater Res A; 2007 Jun; 81(3):515-22. PubMed ID: 17133447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Injectable biodegradable temperature-responsive PLGA-PEG-PLGA copolymers: synthesis and effect of copolymer composition on the drug release from the copolymer-based hydrogels.
    Qiao M; Chen D; Ma X; Liu Y
    Int J Pharm; 2005 Apr; 294(1-2):103-12. PubMed ID: 15814234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Controlled release of bioactive doxorubicin from microspheres embedded within gelatin scaffolds.
    Defail AJ; Edington HD; Matthews S; Lee WC; Marra KG
    J Biomed Mater Res A; 2006 Dec; 79(4):954-62. PubMed ID: 16941588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cellular uptake mechanisms and intracellular distributions of polysorbate 80-modified poly (D,L-lactide-co-glycolide) nanospheres for gene delivery.
    Tahara K; Yamamoto H; Kawashima Y
    Eur J Pharm Biopharm; 2010 Jun; 75(2):218-24. PubMed ID: 20332026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.